PREP Biopharm
Develops respiratory infectious disease products
PREP Biopharm has raised €29M across 1 funding round, most recently a Series A round in Nov 2015. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UK
Total raised
€29M
€29,239,766
Funding rounds
1
Investors
0
distinct backers
Active since
2015-11
latest 2015-11
Funding by year
EUR raised per yearPREP Biopharm — funding by year — interactive chart.
Data table
| PREP Biopharm — funding by year | |
|---|---|
| 2015 | €29M |
Signals
Medium confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-11-01 | Series A | €29M | — | View deal → |